Home > Journals > China Journal of Chinese Materia Medica >Issue 11,2020
China Journal of Chinese Materia Medica
Translated from the Chinese edition
Supervisor(s): China Association for Science and Technology
Sponsor(s): Institute of Chinese Pharmaceutical Association
CN:11-2272/R

24 issues per year

Current Issue: Issue 11, 2020  

Total Downloads:1216

Journal official website:http://zgzye.cbpt.cnki.net/WKE/WebPublication/index.aspx?mid=zgzye

  • China Journal of Chinese Materia Medica, the 1st in the field of TCM, is supervised by China Association for Science and Technology and sponsored by Institute of Chinese Pharmaceutical Association. The journal is China's earliest comprehensive core journal of traditional Chinese medicine, and always maintains the circulation top in the professional areas. The journal publishes the latest research and progress of traditional Chinese medicine and takes a leading position in numbers of articles published, downloads and citations among all journals in this discipline. Its scope covers new achievements, technologies, methods, experiences and concepts resulting from the research on Chinese materia medica pursuant to Chinese medical and pharmaceutical theories, traditional experiences, and modern science and technology, including medicinal resources and identification, cultivation, processing, preparation, chemistry, pharmacology, theory of Chinese pharmacy and clinical practice, bencaological study. The journal is included in CA, JST and CSCD.

  • Honorary Editor-in-Chief
    Xiao Peigen
    Editor-in-Chief
    Wang Yongyan

    Associate Editors
    Zhang Boli, Hu Zhibi, Yao Xinsheng, Li Lianda, Li Dapeng, Yang Baofeng, Zhou Chaofan, Huang Luqi, Chen Shilin, Li He.

    Executive Editorial Board
    Cai Shaoqing, Chen Shilin

Effect of Guanxin Danshen Formula on diabetic kidney disease in db/db mice through regulation of Nrf2 pathway

ZHANG Bin;ZHANG Xue-lian;ZHANG Chen-yang;SUN Gui-bo;SUN Xiao-bo

China Journal of Chinese Materia Medica,2020,Vol 45,No. 11

A new antiviral isoquinoline alkaloid from Thalictrum glandulosissimum

LUO Dian;LYU Na;LIAO Ling-min;GAO Qian;LI Yin-ke;LI Jing;LIU Xin;LI Xue-mei;YANG Guang-yu;YE Yan-qing;HU Qiu-fen;DONG Miao

China Journal of Chinese Materia Medica,2020,Vol 45,No. 11

Study on anti-inflammatory active components and mechanism of Corydalis Bungeanae Herba

LI Mu-zi;ZHANG Hao;CUI Guo-qian;XIANG Yan;ZHU Fen-xia

China Journal of Chinese Materia Medica,2020,Vol 45,No. 11

Expression analysis of transcription factor ERF gene family of Panax ginseng

ZHANG Jie;LIU Juan;JIANG Chao;NAN Tie-gui;KANG Li-ping;ZHOU Li;YUAN Yuan;HUANG Lu-qi

China Journal of Chinese Materia Medica,2020,Vol 45,No. 11

Determination of heavy metal contents in Gardeniae Fructus and fried Gardeniae Fructus and their health risk assessment

LI Xiao-qi;WANG Qi;CHEN Yan

China Journal of Chinese Materia Medica,2020,Vol 45,No. 11

Simultaneous determination of four components of Shuganning Injection in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study

KANG Ning-fang;LI Mei;HU He-jia;XIAO Hong-qin;LIU Li-qin;LI Yin;LI Yue-ting;WANG Ai-min;WANG Yong-lin;ZHANG Yun;HE Feng;GONG Zi-peng

China Journal of Chinese Materia Medica,2020,Vol 45,No. 11

Inhibitory effect of paeonol on aortic endothelial inflammation in atherosclerotic rats by up-regulation of caveolin-1 expression and suppression of NF-κB pathway

LIU Ya-rong;SHAO Qian;ZHANG Hui-hui;JIA Ying;DAI Min

China Journal of Chinese Materia Medica,2020,Vol 45,No. 11

Network Meta-analysis of oral Chinese patent medicine in treatment of acute cerebral infarction

CUI Rui-zhao;YU Dan-dan;LI Hui-min;HU Rui-xue;ZHAO Hui;LIAO Xing

China Journal of Chinese Materia Medica,2020,Vol 45,No. 11